Galanis, E., Anderson, S. K., Twohy, E. L., Carrero, X. W., Dixon, J. G., Tran, D. D., . . . Schiff, D. (2019). A Phase I and Randomized Placebo-Controlled Phase II Trial of Bevacizumab plus Dasatinib in Patients with Recurrent Glioblastoma (GBM): Alliance/NCCTG N0872. Cancer.
Chicago-стиль цитированияGalanis, Evanthia, et al. "A Phase I and Randomized Placebo-Controlled Phase II Trial of Bevacizumab Plus Dasatinib in Patients With Recurrent Glioblastoma (GBM): Alliance/NCCTG N0872." Cancer 2019.
MLA-цитированиеGalanis, Evanthia, et al. "A Phase I and Randomized Placebo-Controlled Phase II Trial of Bevacizumab Plus Dasatinib in Patients With Recurrent Glioblastoma (GBM): Alliance/NCCTG N0872." Cancer 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.